World Online News Reports
SEE OTHER BRANDS

Your top news on global issues

World Online News Reports: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Online News Reports.

Press releases published on April 23, 2025

Raymond James Financial Reports Fiscal Second Quarter of 2025 Results

Raymond James Financial Reports Fiscal Second Quarter of 2025 Results

ST. PETERSBURG, Fla., April 23, 2025 (GLOBE NEWSWIRE) -- Quarterly net revenues of $3.40 billion, up 9% over the prior year’s fiscal second quarter and down 4% compared to the preceding quarter Quarterly net income available to common shareholders of $493 …

Silvaco Announces Date of First Quarter 2025 Financial Results Conference Call

Silvaco Announces Date of First Quarter 2025 Financial Results Conference Call

SANTA CLARA, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO, “Silvaco”), a provider of TCAD, EDA software, and SIP solutions that enable innovative semiconductor design and digital twin modeling through AI software and …

John B. Sanfilippo & Son, Inc. 3rd Quarter Fiscal Year 2025 Operating Results Conference Call

John B. Sanfilippo & Son, Inc. 3rd Quarter Fiscal Year 2025 Operating Results Conference Call

Elgin, IL, April 23, 2025 (GLOBE NEWSWIRE) -- John B. Sanfilippo …

Artesian Water Company Announces the Hiring of Deirdre S. Smith, P.E., as Director of Planning

Artesian Water Company Announces the Hiring of Deirdre S. Smith, P.E., as Director of Planning

NEWARK, Del., April 23, 2025 (GLOBE NEWSWIRE) -- Artesian Water Company, a subsidiary of Artesian Resources Corporation (Nasdaq: ARTNA), announces that Deirdre S. Smith, P.E., has joined the Company as Director of Planning. In her new role, Ms. Smith is …

Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025

Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025

Data from Cohorts 1-3 of trial to be presented in an oral session and poster at the Society for Investigative Dermatology (SID) 2025 Annual Meeting Company to discuss data on its first quarter 2025 business update conference call and webcast scheduled for …

Getty Images to Release First Quarter 2025 Financial Results on May 12, 2025

Getty Images to Release First Quarter 2025 Financial Results on May 12, 2025

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Getty Images Holdings, Inc. (“Getty Images”) (NYSE: GETY) a preeminent global visual content creator and marketplace, announced today that the company intends to release its first quarter 2025 results after …

First Watch Announces Flagship Location in Heart of Downtown Boston

First Watch Announces Flagship Location in Heart of Downtown Boston

BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading daytime restaurant serving breakfast, brunch and lunch, announced it will open its first downtown Boston location in …

Churchill Downs Incorporated Announces Updates on Capital Projects for Churchill Downs Racetrack

Churchill Downs Incorporated Announces Updates on Capital Projects for Churchill Downs Racetrack

LOUISVILLE, Ky., April 23, 2025 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (“CDI” or “the Company”) (Nasdaq: CHDN) announced today renovations of the existing Finish Line Suites and The Mansion at Churchill Downs Racetrack with expected completion in …

Open Lending to Announce First Quarter 2025 Results on May 7, 2025

Open Lending to Announce First Quarter 2025 Results on May 7, 2025

AUSTIN, Texas, April 23, 2025 (GLOBE NEWSWIRE) -- Open Lending Corporation (NASDAQ: LPRO) (“Open Lending” or the “Company”), an industry trailblazer in automotive lending enablement and risk analytics solutions for financial institutions, today announced …

Brookline Bancorp Announces First Quarter Results

Brookline Bancorp Announces First Quarter Results

Net Income of $19.1 million, EPS of $0.21 Operating Earnings of $20.0 million, Operating EPS of $0.22 Quarterly Dividend of $0.135 BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Brookline Bancorp, Inc. (NASDAQ: BRKL) (the “Company”) today announced net income …

Remitly to Report First Quarter Financial Results on May 7, 2025

Remitly to Report First Quarter Financial Results on May 7, 2025

SEATTLE, April 23, 2025 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of digital financial services that transcend borders, today announced that it will report first quarter financial results after the market close …

BBSI Sets First Quarter 2025 Conference Call for Wednesday, May 7, 2025, at 5:00 p.m. ET

BBSI Sets First Quarter 2025 Conference Call for Wednesday, May 7, 2025, at 5:00 p.m. ET

VANCOUVER, Wash., April 23, 2025 (GLOBE NEWSWIRE) -- Barrett Business Services, Inc. (BBSI) (NASDAQ: BBSI), a leading provider of business management solutions and one of the largest professional employer organizations (PEO) in the U.S., will conduct a …

Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025

Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025

SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …

 ACV to Report First Quarter 2025 Financial Results on May 7, 2025

ACV to Report First Quarter 2025 Financial Results on May 7, 2025

BUFFALO, N.Y., April 23, 2025 (GLOBE NEWSWIRE) -- ACV (NYSE: ACVA), a leading digital automotive marketplace and data services partner for dealers and commercial clients, announced today that the Company will report first quarter 2025 financial results …

OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th

OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th

BETHLEHEM, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2025 financial results and certain business developments for 5 p.m. ET on May 7, 2025. A …

Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025

Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025

WEST LAFAYETTE, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research …

Dynagas LNG Partners LP Declares Cash Distribution on Its Series A Preferred Units

Dynagas LNG Partners LP Declares Cash Distribution on Its Series A Preferred Units

ATHENS, Greece, April 23, 2025 (GLOBE NEWSWIRE) -- Dynagas LNG Partners LP (the “Partnership”) (NYSE: “DLNG”), an owner and operator of LNG carriers, today announced that its Board of Directors has declared a cash distribution of $0.5625 per unit on its …

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on January 31, 2025, the company issued inducement awards …

Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients

Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the United States Patent and …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service